S. Yamashita

M. Uchino, S. Yamashita, T. Hirahara, 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Muscle-dominant wild-type TDP-43 expression induces myopathological changes featuring tubular aggregates and TDP-43-positive inclusions

Yasuhiro Yamamoto, H. Maruyama, Y. Ando, 2018, Experimental Neurology.

Sporadic juvenile amyotrophic lateral sclerosis caused by mutant FUS/TLS: possible association of mental retardation with this mutation

T. Suga, M. Uchino, S. Yamashita, 2012, Journal of Neurology.

A mutant MATR3 mouse model to explain multisystem proteinopathy

H. Maruyama, Y. Ando, S. Yamashita, 2019, The Journal of pathology.

Tongue strength in patients with subacute myelo-optico-neuropathy

Y. Ando, S. Yamashita, M. Ueda, 2018, Journal of Clinical Neuroscience.

Adenovirus-Mediated Murine Interferon-γ Receptor Transfer Enhances the Efficacy of IFN-γ in Vivo

M. Uchino, S. Yamashita, E. Uyama, 2002 .

Optineurin is potentially associated with TDP‐43 and involved in the pathogenesis of inclusion body myositis

M. Uchino, S. Yamashita, N. Tawara, 2013, Neuropathology and applied neurobiology.

Tumefactive multiple sclerosis.

M. Uchino, S. Yamashita, T. Hirano, 2009, Internal medicine.

Muscle Fiber Type-Predominant Promoter Activity in Lentiviral-Mediated Transgenic Mouse

M. Ikawa, J. Chamberlain, T. Suga, 2011, Neuromuscular Disorders.

Drastic Therapy for Listerial Brain Abscess Involving Combined Hyperbaric Oxygen Therapy and Antimicrobial Agents

Y. Ando, T. Suga, S. Yamashita, 2014, Journal of clinical neurology.

Effective repetitive dystrophin gene transfer into skeletal muscle of adult mdx mice using a helper‐dependent adenovirus vector expressing the coxsackievirus and adenovirus receptor (CAR) and dystrophin

M. Uchino, S. Yamashita, E. Uyama, 2005 .

Long-Term Outcome of Polymyositis Treated with High Single-Dose Alternate-Day Prednisolone Therapy

T. Suga, M. Uchino, S. Yamashita, 2012, European Neurology.

A novel GJB1 frameshift mutation produces a transient CNS symptom of X-linked Charcot–Marie–Tooth disease

M. Uchino, S. Yamashita, H. Sakaguchi, 2011, Journal of Neurology.

Derlin-1 overexpression ameliorates mutant SOD1-induced endoplasmic reticulum stress by reducing mutant SOD1 accumulation

T. Suga, M. Uchino, S. Yamashita, 2011, Neurochemistry International.

Effect of sildenafil citrate (Viagra) on erectile dysfunction in a patient with familial amyloidotic polyneuropathy ATTR Val30Met.

Y. Ando, M. Suga, M. Uchino, 2000, Journal of the autonomic nervous system.

Cre/loxP-mediated adenovirus type 5 packaging signal excision demonstrates that core element VI is sufficient for virus packaging.

M. Uchino, S. Yamashita, Y. Maeda, 2003, Virology.

Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation

H. Jono, Y. Ando, S. Yamashita, 2016, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Fulminant myelopathy following neurogenic proximal weakness associated with human T-cell lymphotropic virus type I infection.

M. Uchino, S. Yamashita, T. Hirahara, 2011, Internal medicine.

Usefulness of intraventricular infusion of antifungal drugs through Ommaya reservoirs for cryptococcal meningitis treatment

J. Kuratsu, S. Yano, Y. Ando, 2015, Journal of the Neurological Sciences.

Muscle biopsy findings predictive of malignancy in rare infiltrative dermatomyositis

Y. Ando, T. Suga, M. Uchino, 2013, Clinical Neurology and Neurosurgery.

Hypoxia suppresses cylindromatosis (CYLD) expression to promote inflammation in glioblastoma: possible link to acquired resistance to anti-VEGF therapy

J. Kuratsu, Jian-Dong Li, H. Jono, 2014, Oncotarget.

Long-term effects of edaravone on survival of patients with amyotrophic lateral sclerosis

Yukio Ando, Yasushi Maeda, Masatoshi Ishizaki, 2018, eNeurologicalSci.

New Type of Sendai Virus Vector Provides Transgene-Free iPS Cells Derived from Chimpanzee Blood

T. Matsuzawa, M. Hamasaki, S. Kimura, 2014, PloS one.

Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis

Y. Ando, S. Yamashita, 2015, Translational Neurodegeneration.

Amyotrophic lateral sclerosis (ALS) is the adult-onset paralytic disease and is characterized by a loss of motor neurons in the cerebral cortex, brainstem, and spinal cord

M. Uchino, S. Yamashita, T. Hirano, 2010 .

Osteopontin‐integrin αvβ3 axis is crucial for 5‐fluorouracil resistance in oral squamous cell carcinoma

H. Jono, Y. Ando, S. Yamashita, 2015, FEBS letters.

Mdx respiratory impairment following fibrosis of the diaphragm

T. Suga, M. Uchino, S. Yamashita, 2008, Neuromuscular Disorders.

Significant CMAP decrement by repetitive nerve stimulation is more frequent in median than ulnar nerves of patients with amyotrophic lateral sclerosis

M. Uchino, S. Yamashita, H. Sakaguchi, 2012, Muscle & nerve.

DJ-1 forms complexes with mutant SOD1 and ameliorates its toxicity

M. Uchino, S. Yamashita, T. Hirano, 2010, Neuroscience Research.

Myasthenic crisis patients who require intensive care unit management

M. Uchino, S. Yamashita, H. Sakaguchi, 2012, Muscle & nerve.

HLA-DRB1 allele and autoantibody profiles in Japanese patients with inclusion body myositis

T. Shiina, I. Nishino, Shigeaki Suzuki, 2020, PloS one.

Clinical significance of CYLD downregulation in breast cancer

Aiko Sueta, Jian-Dong Li, H. Jono, 2014, Breast Cancer Research and Treatment.

The updated retrospective questionnaire study of sporadic inclusion body myositis in Japan

I. Nishino, R. Kaji, H. Nodera, 2019, Orphanet Journal of Rare Diseases.

Staphylococcus cohnii as a cause of multiple brain abscesses in Weber–Christian disease

Ryoko Sugimoto, M. Uchino, S. Yamashita, 2005, Journal of the Neurological Sciences.

Stromal expression of neutrophil gelatinase‐associated lipocalin correlates with poor differentiation and adverse prognosis in oral squamous cell carcinoma

H. Jono, Y. Ando, S. Yamashita, 2014, Histopathology.

Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis

D. Papanicolaou, V. S. Williams, L. Tankó, 2020, Neurology.

Multicenter questionnaire survey for sporadic inclusion body myositis in Japan

I. Higuchi, I. Nishino, S. Nakano, 2017, Journal of the Neurological Sciences.

Pathomechanisms of anti–cytosolic 5′‐nucleotidase 1A autoantibodies in sporadic inclusion body myositis

Y. Ando, S. Yamashita, T. Doki, 2017, Annals of neurology.

Clinical features of Japanese patients with inclusion body myositis

Y. Ando, S. Yamashita, N. Tawara, 2014, Journal of the Neurological Sciences.

Regions downstream from the WW domain of dystrophin are important for binding to postsynaptic densities in the brain

M. Uchino, S. Yamashita, T. Hirano, 2008, Neuromuscular Disorders.

Rescue from respiratory dysfunction by transduction of full-length dystrophin to diaphragm via the peritoneal cavity in utrophin/dystrophin double knockout mice.

T. Suga, M. Uchino, S. Yamashita, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Efficient repetitive gene delivery to skeletal muscle using recombinant adenovirus vector containing the Coxsackievirus and adenovirus receptor cDNA

M. Uchino, S. Yamashita, E. Uyama, 2001, Gene Therapy.

Clinicopathological features of the first Asian family having vocal cord and pharyngeal weakness with distal myopathy due to a MATR3 mutation

S. Tsuji, S. Morishita, Y. Ando, 2015, Neuropathology and applied neurobiology.

CMAP decrement as a potential diagnostic marker for ALS

S. Yamashita, M. Nakajima, Y. Misumi, 2016, Acta neurologica Scandinavica.

Anti‐NT5C1A autoantibodies for the diagnosis and study of the pathogenesis of sporadic inclusion body myositis

S. Yamashita, N. Tawara, Y. Ando, 2017 .

Cerebral amyloid angiopathy-related inflammation presenting with steroid-responsive higher brain dysfunction: case report and review of the literature

M. Uchino, S. Yamashita, H. Sakaguchi, 2011, Journal of Neuroinflammation.

An adult norovirus-related encephalitis/encephalopathy with mild clinical manifestation

M. Uchino, S. Yamashita, T. Hirano, 2010, BMJ Case Reports.

A Randomized Phase 2 Trial of Antibiotic Prophylaxis Versus No Intervention for Muscle Biopsy in A Neurology Department.

S. Yamashita, K. Hara, N. Tawara, 2020, Acta medica Okayama.

Hemiatrophy of the Tongue with Contralateral Hemiparesis in a Patient with Multifocal Acquired Demyelinating Sensory and Motor Neuropathy

Y. Ando, S. Yamashita, Y. Misumi, 2017, Journal of clinical neurology.

Coexistence of Amyotrophic Lateral Sclerosis and Myasthenia Gravis.

Y. Ando, M. Uchino, S. Yamashita, 2014, Journal of neuromuscular diseases.

Meningitis and Ventriculitis due to Nocardia araoensis Infection

Y. Ando, S. Yamashita, H. Kawano, 2017, Internal medicine.

Concomitant accumulation of α-synuclein and TDP-43 in a patient with corticobasal degeneration

M. Hasegawa, Y. Ando, Yukio Fujiwara, 2014, Journal of Neurology.

Anti-NXP2 antibody-positive dermatomyositis with aortic thrombus in normal aortic wall.

N. Okiyama, Y. Ando, S. Yamashita, 2021, Rheumatology.

Effect of thymectomy for thymic atrophy in myasthenia gravis: A retrospective study on 93 patients

Y. Ando, S. Yamashita, Takeshi Mori, 2017, Journal of Neuroimmunology.

Acute ophthalmoparesis accompanied with Influenza A infection.

M. Uchino, S. Yamashita, Ryoko Kawano, 2008, Internal medicine.

Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial

D. Papanicolaou, V. S. Williams, P. Bergh, 2019, The Lancet Neurology.

Assessment of oropharyngeal swallowing dysfunction in myasthenia gravis patients presenting with difficulty in swallowing.

Y. Ando, S. Yamashita, Takumi Miyamoto, 2019, Auris, nasus, larynx.

Effect of intravenous immunoglobulin therapy on anti-NT5C1A antibody-positive inclusion body myositis after successful treatment of hepatitis C: A case report

K. Abe, S. Yamashita, N. Morimoto, 2019, eNeurologicalSci.

Macroglossia in rapidly progressive inclusion body myositis

Y. Ando, S. Yamashita, N. Tawara, 2022, Neuropathology : official journal of the Japanese Society of Neuropathology.

Binasal hemianopia caused by bilateral optic perineuritis due to sarcoidosis

S. Yamashita, N. Tawara, S. Nakane, 2021, eNeurologicalSci.

Gender differences in clinical features at the initial examination of late-onset amyotrophic lateral sclerosis

S. Yamashita, K. Hara, N. Tawara, 2023, Journal of the Neurological Sciences.

Decision making of amyotrophic lateral sclerosis patients on noninvasive ventilation to receive tracheostomy positive pressure ventilation

Y. Ando, M. Uchino, S. Yamashita, 2014, Clinical Neurology and Neurosurgery.

Abnormal spinal MRI findings in human T-cell lymphotrophic virus type I-associated myelopathy

M. Uchino, S. Yamashita, Masaki Watanabe, 2009, Clinical Neurology and Neurosurgery.

Myopathic changes caused by protein aggregates in adult-onset spinal muscular atrophy.

I. Nishino, S. Yamashita, M. Ueda, 2023, Neuropathology (Kyoto. 1993).

Muscle pathology of hereditary motor and sensory neuropathy with proximal dominant involvement with TFG mutation

Y. Ando, S. Yamashita, K. Hara, 2019, Muscle & nerve.

Gait Disturbance due to Foot Drop Is Refractory to Treatment in Nonsystemic Vasculitic Neuropathy

Y. Ando, S. Yamashita, Masaki Watanabe, 2014, European Neurology.

Diffusion and ADC-map images detect ongoing demyelination on subcortical white matter in an adult metachromatic leukodystrophy patient with autoimmune Hashimoto thyroiditis

M. Uchino, S. Yamashita, T. Hirano, 2010, BMJ Case Reports.

Correction: Efficient and Reproducible Myogenic Differentiation from Human iPS Cells: Prospects for Modeling Miyoshi Myopathy In Vitro

N. Fujii, K. Woltjen, K. Isobe, 2013, PLoS ONE.

Determination of cN1A Autoantibodies by Cell-Based Immunofluorescence Cytochemistry.

S. Yamashita, N. Tawara, 2018, Methods in molecular biology.

Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-Term Extension of RESILIENT.

D. Papanicolaou, V. S. Williams, L. Tankó, 2021, Neurology.

Impact of major earthquakes on Parkinson’s disease

S. Yamashita, K. Nakahara, S. Nakane, 2019, Journal of Clinical Neuroscience.

Cerebrotendinous xanthomatosis presenting with extensive cerebral cortex symptoms: A case report

Y. Ando, S. Yamashita, A. Mukaino, 2018, Clinical Neurology and Neurosurgery.

Long-Term Outcome of Polymyositis Treated with High Single-Dose Alternate-Day Prednisolone Therapy

T. Suga, M. Uchino, S. Yamashita, 2012, European Neurology.

Heatstroke in patients with Parkinson’s disease

M. Uchino, S. Yamashita, H. Sakaguchi, 2012, Neurological Sciences.

Biological significance of target fibres in amyotrophic lateral sclerosis

S. Yamashita, K. Hara, N. Tawara, 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

Is 123I-MIBG Scintigraphy Beneficial or Excessive for the Diagnosis of Parkinson’s Disease in the Early Phase?

S. Shiraishi, S. Yamashita, K. Nakahara, 2019, Neurodegenerative Diseases.